The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Autocrine TGF-β1/miR-200s/miR-221/DNMT3B regulatory loop maintains CAF status to fuel breast cancer cell proliferation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, TGF-β1 derived from cancer cells can reduce miR-200 expression and, thus, help activate CAFs [135].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [135]
In the citing paper
“On the other hand, miR-141 inhibition in these cells increases the expression of transcription factor 12 (TCF12) to facilitate the growth of breast cancer cells through CXCL12 secretion in CAFs, which leads to increased c-Myc and cyclin D1 expression in breast cancer cells, thus allowing these cells to undergo immortality through c-Myc activation [135].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [135]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Tauriello, D. V. F., Palomo-Ponce, S., Stork, D., Berenguer-Llergo, A., Badia-Ramentol, J., Iglesias, M., Sevillano, M., Ibiza, S., Cañellas, A., Hernando-Momblona, X., et al. (2018) · Nature · doi:10.1038/nature25492 · Cited by 1,851
Microenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847 · cited 1×
“CXCL12, CCL2 and VEGF are the known factors, secreted by CAFs, to induce progression of cancer cells [26; 27; 28], thus we tested whether these factors are responsible for TCF12stimulated proliferation of breast cancer cells.”
BackgroundCalvo, F., Ege, N., Grande-Garcia, A., Hooper, S., Jenkins, R. P., Chaudhry, S. I., Harrington, K., Williamson, P., Moeendarbary, E., Charras, G., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2756 · Cited by 1,478
Research works printed but not linked: 40
- Kalluri, 2016, The biology and function of fibroblasts in cancer, Nat. Rev. Canc., 16, 582, 10.1038/nrc.2016.73 · DOI · Paper page
- La Porta, 2018, Explaining the dynamics of tumor aggressiveness: at the crossroads between biology, artificial intelligence and complex systems, Semin. Canc. Biol., 53, 42, 10.1016/j.semcancer.2018.07.003 · DOI · Paper page
- Wang, 2013, c-Ski activates cancer-associated fibroblasts to regulate breast cancer cell invasion, Mol Oncol, 7, 1116, 10.1016/j.molonc.2013.08.007 · DOI · Paper page
- Karakasheva, 2018, IL-6 mediates cross-talk between activated fibroblasts and tumor cells in the tumor microenvironment, Cancer Res., 78, 4957, 10.1158/0008-5472.CAN-17-2268 · DOI · Paper page
- Madar, 2013, 'Cancer associated fibroblasts'--more than meets the eye, Trends Mol. Med., 19, 447, 10.1016/j.molmed.2013.05.004 · DOI
- Gascard, 2016, Carcinoma-associated fibroblasts: orchestrating the composition of malignancy, Genes Dev., 30, 1002, 10.1101/gad.279737.116 · DOI
- Qiu, 2008, No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas, Nat. Genet., 40, 650, 10.1038/ng.117 · DOI
- Jiang, 2008, Global hypomethylation of genomic DNA in cancer-associated myofibroblasts, Cancer Res., 68, 9900, 10.1158/0008-5472.CAN-08-1319 · DOI
- Hu, 2005, Distinct epigenetic changes in the stromal cells of breast cancers, Nat. Genet., 37, 899, 10.1038/ng1596 · DOI
- Albrengues, 2015, Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts, Nat. Commun., 6, 10204, 10.1038/ncomms10204 · DOI
- Xiao, 2016, Cancer-associated fibroblasts in pancreatic cancer are reprogrammed by tumor-induced alterations in genomic DNA methylation, Cancer Res., 76, 5395, 10.1158/0008-5472.CAN-15-3264 · DOI
- Ling, 2016, Human colorectal cancer stage-dependent global DNA hypomethylation of cancer-associated fibroblasts, Anticancer Res., 36, 4503, 10.21873/anticanres.10996 · DOI
- Tang, 2016, Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling, Cell Death Differ., 23, 132, 10.1038/cdd.2015.78 · DOI · Paper page
- Cursons, 2018, Combinatorial targeting by MicroRNAs Co-ordinates post-transcriptional control of EMT, Cell Syst, 7, 77, 10.1016/j.cels.2018.05.019 · DOI
- Davalos, 2012, Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis, Oncogene, 31, 2062, 10.1038/onc.2011.383 · DOI
- Pan, 2013, Transforming growth factor beta1 induces the expression of collagen type I by DNA methylation in cardiac fibroblasts, PLoS One, 8
- Neveu, 2015, TGF-beta1 epigenetically modifies Thy-1 expression in primary lung fibroblasts, Am. J. Physiol. Cell Physiol., 309, C616, 10.1152/ajpcell.00086.2015 · DOI
- Sanders, 2017, Epigenetic regulation of caveolin-1 gene expression in lung fibroblasts, Am. J. Respir. Cell Mol. Biol., 56, 50, 10.1165/rcmb.2016-0034OC · DOI · Paper page
- Kojima, 2010, Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts, Proc. Natl. Acad. Sci. U. S. A., 107, 20009, 10.1073/pnas.1013805107 · DOI
- Li, 2002, MethPrimer: designing primers for methylation PCRs, Bioinformatics, 18, 1427, 10.1093/bioinformatics/18.11.1427 · DOI
- Lamprecht, 2018, Teaming up for trouble: cancer cells, transforming growth factor-beta1 signaling and the epigenetic corruption of stromal naive fibroblasts, Cancers, 10, 10.3390/cancers10030061 · DOI
- Yu, 2014, Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling, Br. J. Canc., 110, 724, 10.1038/bjc.2013.768 · DOI
- Megiorni, 2016, DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation, Oncotarget, 7, 79342, 10.18632/oncotarget.12688 · DOI
- T, 2015, Oxidized ATM promotes abnormal proliferation of breast CAFs through maintaining intracellular redox homeostasis and activating the PI3K-AKT, MEK-ERK, and Wnt-β-catenin signaling pathways, Cell Cycle, 14, 1908, 10.1080/15384101.2015.1041685 · DOI
- Mezawa, 2016, The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas, Cell Tissue Res., 365, 675, 10.1007/s00441-016-2471-1 · DOI
- Shen, 2016, Reprogramming of normal fibroblasts into cancer-associated fibroblasts by miRNAs-mediated CCL2/VEGFA signaling, PLoS Genet., 12, 10.1371/journal.pgen.1006244 · DOI
- Fallah, 2017, MYC-driven pathways in breast cancer subtypes, Biomolecules, 7, 10.3390/biom7030053 · DOI
- Musgrove, 1994, Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle, Proc. Natl. Acad. Sci. U.S.A., 91, 8022, 10.1073/pnas.91.17.8022 · DOI
- Sun, 2018, Primed atypical ductal hyperplasia-associated fibroblasts promote cell growth and polarity changes of transformed epithelium-like breast cancer MCF-7 cells via miR-200b/c-IKKβ signaling, Cell Death Dis., 9, 122, 10.1038/s41419-017-0133-1 · DOI
- Giordano, 2016, Activated FXR inhibits leptin signaling and counteracts tumor-promoting activities of cancer-associated fibroblasts in breast malignancy, Sci. Rep., 6, 21782, 10.1038/srep21782 · DOI
- Zagorac, 2016, DNMT1 inhibition reprograms pancreatic cancer stem cells via upregulation of the miR-17-92 cluster, Cancer Res., 76, 4546, 10.1158/0008-5472.CAN-15-3268 · DOI
- Fiaschetti, 2014, Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma, Br. J. Canc., 110, 636, 10.1038/bjc.2013.764 · DOI
- Li, 2015, Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment, Cell Res., 25, 588, 10.1038/cr.2015.51 · DOI
- Aprelikova, 2013, Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility, Oncogene, 32, 3246, 10.1038/onc.2012.351 · DOI
- De Kumar, 2017, Dynamic regulation of Nanog and stem cell-signaling pathways by Hoxa1 during early neuro-ectodermal differentiation of ES cells, Proc. Natl. Acad. Sci. U. S. A., 114, 5838, 10.1073/pnas.1610612114 · DOI
- Zhang, 2017, DNA methyltransferases and their roles in tumorigenesis, Biomark Res, 5, 1, 10.1186/s40364-017-0081-z · DOI
- Sarabi, 2015, Association of DNA methyltransferases expression with global and gene-specific DNA methylation in colorectal cancer cells, Cell Biochem. Funct., 33, 427, 10.1002/cbf.3126 · DOI
- Zhang, 2016, Mechanical stress regulates osteogenic differentiation and RANKL/OPG ratio in periodontal ligament stem cells by the Wnt/beta-catenin pathway, Biochim. Biophys. Acta, 1860, 2211, 10.1016/j.bbagen.2016.05.003 · DOI
- Vizoso, 2015, Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts, Carcinogenesis, 36, 1453
- Hendrayani, 2016, The inflammatory/cancer-related IL-6/STAT3/NF-kappaB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts, Oncotarget, 7, 41974, 10.18632/oncotarget.9633 · DOI
Cited by
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
Chalak, M., Hesaraki, M., Mirbahari, S. N., Yeganeh, M., Abdi, S., Rajabi, S., & Hemmatzadeh, F. (2024) · Life · doi:10.3390/life14030417 · Cited by 66
Metadata
- Authors
- Tang, X., Tu, G., Yang, G., Wang, X., Kang, L., Yang, L., Zeng, H., Wan, X., Qiao, Y., Cui, X., Liu, M., & Hou, Y.
- ORCID
- Kang, Linmin
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 452
- Pages
- 79-89
- ISSN
- 0304-3835
- PMC
- PMC7560952
- Cited by
- 76
- References
- 3
- Language
- en
- Funders
- National Natural Science Foundation of China (NSFC 81773078, NSFC 81402180, NSFC 81472476, NSFC 31671481, NSFC 81802653)
- First Affiliated Hospital of Chongqing Medical University (PYJJ2018-04)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review